Bovine aortic smooth-muscle cells, bovine aortic endothelial cells, and IMR-90 human embroyonic lung fibroblasts were tested to determine their ability to use cysteine or cysteine metabolites as a source of sulphate (SO4). Cells were incubated in SO4-depleted medium containing [3H]glucosamine plus 0.2 mMcystine, 0.3 mM-cysteinesulphinic acid or 0.3 mM-sulphite (SO3). The [3H]chondroitin sulphate produced by the different cells was found to vary considerably in degree of sulphation under these conditions. One line of smooth-muscle cells utilized cysteine effectively as a S04 source and thus produced chondroitin sulphate which was highly sulphated. IMR-90 fibroblasts produced partly sulphated chondroitin sulphate under these conditions, while another smooth-muscle cell line could not utilize cysteine, but could utilize cysteinesulphinic acid as a partial S04 source. In contrast with the above cells, endothelial cells could not use cysteine or cysteinesulphinic acid as a source of S04 and produced chondroitin with almost no SO4. All of the cells were Furthermore, the addition of 0.4 mm inorganic S04 did not inhibit the production of S04 from cysteine by these cells.
INTRODUCTION
Sulphation is a wide-ranging process, occurring in numerous tissues, and involving many substances [1] such as proteoglycans, proteins, lipids, hormones and drugs. It is likely that sulphation is involved in many aspects of function, recognition and excretion, so that the control and degree of S04 substitution may have significant effects on an organism.
Although S04 may be found in various food substances, metabolism of S-containing amino acids is thought to provide the major supply of S04 in vivo [1] . Exogenous cysteine (or cystine), or cysteine formed from serine and the S of methionine, is oxidized to cysteinesulphinate, which can then undergo either decarboxylation or transamination leading to taurine or pyruvate respectively, and S04. The presumed intermediate in the latter pathway is ,-sulphinylpyruvate, which spontaneously decomposes to yield pyruvate and S03. The S03 is then oxidized to S04 by sulphite oxidase, an enzyme which is present in many tissues [2] . Studies with rat liver mitochondria [3] , perfused rat liver [4] , and hepatocytes [5] have indicated that inorganic S04 may also be produced by pathways that are independent of cysteinesulphinate. The percentage of cysteine S converted to taurine rather than to S04 varies substantially among species [6] and probably also varies considerably with cell type. With few exceptions, however, information concerning the formation of S04 from cysteine or methionine is only available for liver cells. Consequently, it is not known if other cells are capable of producing their own supply of S04 or are dependent on external sources of S04.
The major use of S04 by most cells is in the formation of proteoglycans. These proteoglycans can generally be labelled in cell cultures by adding 35SO4 to the growth medium. Thus the cells are apparently capable of obtaining their necessary S04 by direct uptake from extracellular fluids. The cellular uptake of S04 has been shown to be an active process and appears to vary somewhat with cell type [7, 8] . In human IMR-90 lung fibroblasts, S04 uptake has been shown to occur mainly by S04/chloride exchange [7] and is independent of phosphate or Na transport. However, in hepatocytes, transport has been shown to occur by a Na-dependent route as well as a Na-independent route [8] , and is also dependent on bicarbonate.
We have previously cultured bovine aortic endothelial cells [9] and human skin fibroblasts [10] in media containing substantial concentrations of cystine (cysteine) but low concentrations of SO4. The cystine concentration of this medium is characteristic of many different tissue culture media. We found that the concentration of S04 needed for full sulphation of proteochondroitin approached the lower levels of SQ4 found in normal serum, indicating that cysteine was not utilized as a SO4 source by these cells, and suggesting that extracellular sources of S04 might be limiting for Vol. 252 sulphation of chondroitin by some cells in vivo. Undersulphation of chondroitin in the presence of low levels of SO4 has also been demonstrated in cartilage [11, 12] , suggesting that this tissue was incapable of utilizing cysteine as a SO4 source. In contrast with these findings, a specific mutant line of Chinese hamster ovary (CHO) cells has been found to be capable of producing fully sulphated chondroitin [13] Bovine aortic endothelial cells and bovine aortic smooth-muscle cells were obtained from fresh calf aorta after collagenase treatment as described previously [14] . After the cultures were established, they were stored in complete medium containing 1000 dimethyl sulphoxide in a liquid N2 storage bank. IMR-90 human embryonic lung fibroblasts were originally obtained from American Type Culture Collection (Rockville, MD, U.S.A.). After removal from storage, the bovine aortic endothelial cells and smooth-muscle cells were grown to confluence [approx. (1.5-2) x 106 cells] in six-well cluster dishes (Costar) with RPMI-1640 medium containing 20 0 fetal-calf serum. IMR-90 fibroblasts were grown to confluence [approx. (1-1.5) x 106 cells] in MEM plus 10 0 fetal-calf serum. All cells were pre-incubated for 1 h in serum-free S04-free RPMI-1640 (which contains 0.2 mMcystine as a source of cysteine) before labelling in 1.5 ml of the S04-free RPMI-1640 to which [3H1-glucosamine (12 x 106 c.p.m./ml) was added. Cells were cultured in this medium, or in this medium with added 0.3 mM-cysteinesulphinic acid, or with added 0.3 mMNa2SO3. After 5 h, portions (0.5 ml) of the medium were desalted on Sephadex G-50 equilibrated with 0.5 Mammonium bicarbonate. The excluded fractions were pooled, freeze-dried, and re-dissolved in water (0.1 ml). Sulphation of [3H]chondroitin was monitored by digestion of portions (1000 c.p.m.) with chondroitin ABC lyase [15] (0.15 unit, I h, 37°C) in a total volume of 0.02 ml followed by chromatography on Whatman No. 1 paper with a descending system of 1-butanol/acetic acid/ I M-ammonium hydroxide (2:3: 1, by vol.) [15] . All degradations contained 0.15 mg each of chondroitin, chondroitin 4-sulphate and chondroitin 6-sulphate, which yielded ADi-OS, ADi-4S and ADi-6S after degradation, respectively. These unsaturated disaccharides were localized under u.v. light, eluted from the paper with water, and radioactivity was determined by liquidscintillation spectrometry. Detection was accomplished by overnight autoradiography with Kodak X-OMAT X-ray film, and by counting the eluted spots.
RESULTS AND DISCUSSION
The degree of sulphation of the [3H]chondroitin produced by bovine aortic endothelial cells, bovine aortic smooth-muscle cells, and human IMR-90 embryonic lung fibroblasts was examined by paper chromatographic analysis of chondroitin ABC lyase degradation products (Fig. 1) Fig. l(a) (Fig.  1 b) was less than 20 0 sulphated under the same conditions. Also shown in Fig. 1(b) is that these cells appeared to have some ability to utilize cysteinesulphinic acid. However, the chondroitin sulphate produced was only 600% sulphated, indicating that cysteinesulphinic acid could only supply limited amounts of sulphate. Addition of 0.3 mM-Na2SO3 to the medium resulted in fully sulphated chondroitin sulphate, indicating that the cells contained sulphite oxidase. (Na2SO3 was analysed for possible contaminating S04 by the method of Ba precipitation followed by acidification [16] . Less than 2%0 S04 was found which agreed with the lot analysis of > 97%0 S03 provided by Sigma.) When IMR-90 cells (Fig. I c) were incubated in S04-free medium they produced partially sulphated chondroitin (approx. 70°%). Addition of cysteinesulphinic acid did not increase the amount of chondroitin sulphate, while the addition of S03 resulted in the production of chondroitin sulphate which was essentially fully sulphated. Bovine aortic endothelial cells (Fig. 1d ) incubated in S04-free medium containing cysteine or cysteinesulphinic acid produced [3H]chondroitin with essentially no S04. Indeed, these cells require concentrations of S04 higher than 0.1 mm in order to produce fully sulphated chondroitin sulphate [9] . Another bovine endothelial cell line at an earlier passage yielded similar results (not shown). However, like the other cells, these endothelial cells were capable of utilizing SO3 as a S04 source, suggesting that sulphite oxidase might be common to most, if not all, cells. A sulphite oxidase/cytochrome c assay (Sigma) of medium containing SO3 was performed before and after a 20 h control incubation without cells. The results demonstrated that essentially equal amounts of SO3 were present before and after the 20 h incubation. Thus, no appreciable amounts of SO3 (certainly less than 0.1 mM) were spontaneously oxidized to S04, indicating that the production of S04 from SO3 in the 5 h cell culture experiments was enzymic.
To confirm that cysteine was indeed the source of S04 in the S04-free RPMI medium, the early passage smooth-muscle cells and the endothelial cells were incubated in the S04-free RPMI (Fig. I a) Fig. 1 a) . Furthermore, cells having a capability of utilizing cysteine would dilute added 35SO4 with SO4 from their cysteine pool. Results would be particularly distorted if low 35SO4 concentrations were used. Thus failure to recognize a production of SO4 from cysteine could lead to erroneous results in comparing the amounts of 35SO4 incorporated by cells under varying conditions. Undersulphation ofsubstances should also be expected to vary according to the required concentrations of intracellular SO4 and/or adenosine 3'-phosphoadenylylphosphosulphate (PAPS) needed for a specific sulphotransferase. Thus a sulphotransferase with a low Km for PAPS would be less affected under conditions of SO4 deprivation than would a sulphotransferase with a higher Ki,, such as chondroitin sulphotransferase [17] .
For example, the Km with regard to PAPS for phenol sulphotransferase, heparin N-sulphotransferase, heparan N-sulphotransferase and chondroitin sulphotransferase have been reported to be approx. 0.5 /,m [18] , 20 /SM [19] , 50 /iM [20] and 500 /M [17] , respectively. Significant undersulphation therefore would only occur in those compounds requiring high concentrations of PAPS for sulphation.
The results of this paper show that analysis of chondroitin sulphate provides a sensitive measure of SO4 availability. Since most, if not all, cells produce chondroitin sulphate, this should prove useful in determining the capacity of cells to use cysteine, or other Scontaining compounds as precursors of SO4.
